7Baggers

Beyond Air, Inc
(NASDAQ:XAIR) 

XAIR stock logo

Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops inhaled nitric oxide (NO) to treat respiratory infections, and gaseous NO to treat solid tumors. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the...

Founded: 2011
Full Time Employees: 23
CEO: Steven A. Lisi  
Sector: Healthcare
Industry: Medical Devices

Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 4.80
H 5.00
L 4.40
C 4.80
V 1,382,347
10EMA 4.80
20EMA 4.80
60EMA 4.80
120EMA 4.80
250EMA 4.80
XAIR - Daily